10 reasons to buy Trevali- Estimated $380,000 net profit per day coming in September or around $130 mil. per year
- Estimated $640,000 per day in Q1 2012 or about $230 mil. per year
- Double that when both mines ramp up to 4000 TPD from 2000 TPD.
- 10 bil in gross metal value or 6.5 mil. ounces gold-equivalent with around a $160 mil. market cap
- Peer market caps between $400 mil. and 500 mil.
- $30 mil. debt facility with same company that funds Pan American Silver and multi-billionaire Lundin
- At least 2 partnerships with Glencore after they take over Xstrata with IPO on May 19th (Analysts value IPO at $69 Bil.)
- Mega Financiers Axeman Resource Capital raised $13.7 mil. for TV plus $30 Mil for ITH and close to $100 mil. for Cardero group in 9 years
- Axeman made over $ 1 Bil. profit for top fund managers like Hathaway, Prudent Bear Etc with early financings like Atac (high $9.00)
East Asia (high $8.73) Underworld (Takeover) https://www.axemen.net/capital.html
- Management:
Dr. Mark Cruise
Position: President, CEO and Director
A base metal specialist, Mark has extensive global base-metal experience from grassroots exploration through resource definition to production in Europe and the Americas. He completed his Ph.D. on the Irish zinc-lead orefield and was a member of Anglo American's Lisheen Zinc-Lead Mine feasibility/technical team in Ireland that developed the 4,000 tpd Lisheen Mine. In 2001, he transferred to Anglo's Vancouver office, where he held the position of Senior Geologist with responsibility for Anglo's copper and zinc portfolio, including project generation and implementation in Canada, USA and Mexico. In 2004, Mark joined Cardero Resources as Vice President, Exploration, with responsibility for Cardero's Peruvian, Argentinean and Mexican portfolio, including the approximately 850-Mt Pampa de Pongo iron deposit, Peru. In 2008, he joined Trevali where he has been instrumental in the ongoing fast-track redevelopment and planned resumption of production, with partners Glencore International A.G., from three recently discovered deposits at the Santander polymetallic mine project in west-central Peru.
Dr. Anthony (Tony) Holler
Position: Chairman and Director
Dr. Holler brings his expertise in the mergers and acquisitions field to Trevali. Dr. Holler founded and was the Chief Executive Officer of ID Biomedical Corp., where he oversaw product development from research and development through to commercialization. He eventually sold the company to GlaxoSmithKline for approximately $1.7 billion. Similarly, during his tenure as Chairman and Director at Corriente Resources Inc., he oversaw the development of that company's copper/gold property through bankable feasibility, ultimately selling the company for approximately $700 million.